Xencor to Present at the 2021 Cantor Virtual Global Healthcare Conference

Rhea-AI Summary

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company focused on engineered monoclonal antibodies and cytokines, will present at the Cantor Virtual Global Healthcare Conference on September 27, 2021, at 4:00 p.m. ET. The event will be available via live webcast in the Investors section of their website. Xencor is currently developing 22 clinical candidates using its XmAb® technology, which enhances protein structure for innovative therapeutic actions. A replay of the presentation will be accessible for 30 days post-event.

MONROVIA, Calif.--(BUSINESS WIRE)-- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will present at the Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 4:00 p.m. ET / 1:00 p.m. PT.

A live webcast will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. Following the webcast, a replay will be archived on the website for at least 30 days.

About Xencor, Inc.

Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. Currently, 22 candidates engineered with Xencor's XmAb^® technology are in clinical development internally and with partners. Xencor's XmAb antibody engineering technology enables small changes to the structure of proteins resulting in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210920005829/en/

Charles Liles

cliles@xencor.com



Media Contact

Jason I. Spark

Canale Communications

619-849-6005

jason@canalecomm.com

Source: Xencor, Inc.

FAQ

When is Xencor's presentation at the Cantor Virtual Global Healthcare Conference?

Xencor will present on September 27, 2021, at 4:00 p.m. ET.

Where can I watch the Xencor presentation live?

The live webcast of Xencor's presentation can be accessed in the Investors section of their website.

What technology does Xencor use for its drug candidates?

Xencor utilizes its XmAb® technology for developing engineered monoclonal antibodies and cytokines.

How many candidates is Xencor currently developing?

Xencor is developing 22 clinical candidates using its XmAb® technology.

Will the Xencor presentation be available for replay?

Yes, a replay of the presentation will be available for at least 30 days after the event.